Compare ALEMBIC PHARMA with WYETH - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs WYETH - Comparison Results

WYETH 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA WYETH ALEMBIC PHARMA/
WYETH
 
P/E (TTM) x 15.7 27.7 56.5% View Chart
P/BV x 6.2 5.3 116.4% View Chart
Dividend Yield % 0.6 1.3 48.1%  

Financials

 ALEMBIC PHARMA   WYETH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
WYETH
Mar-13
ALEMBIC PHARMA/
WYETH
5-Yr Chart
Click to enlarge
High Rs6641,044 63.6%   
Low Rs412818 50.4%   
Sales per share (Unadj.) Rs208.7298.6 69.9%  
Earnings per share (Unadj.) Rs31.057.2 54.2%  
Cash flow per share (Unadj.) Rs37.158.4 63.5%  
Dividends per share (Unadj.) Rs5.5017.00 32.4%  
Dividend yield (eoy) %1.01.8 56.0%  
Book value per share (Unadj.) Rs144.2249.5 57.8%  
Shares outstanding (eoy) m188.5222.72 829.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.1 82.7%   
Avg P/E ratio x17.416.3 106.7%  
P/CF ratio (eoy) x14.515.9 91.0%  
Price / Book Value ratio x3.73.7 100.0%  
Dividend payout %17.729.7 59.7%   
Avg Mkt Cap Rs m101,46121,157 479.6%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m7,467400 1,866.7%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m39,3476,783 580.0%  
Other income Rs m94353 26.6%   
Total revenues Rs m39,4417,136 552.7%   
Gross profit Rs m8,7361,617 540.1%  
Depreciation Rs m1,15227 4,332.0%   
Interest Rs m1846 3,347.3%   
Profit before tax Rs m7,4931,938 386.7%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,568632 247.9%   
Profit after tax Rs m5,8441,301 449.3%  
Gross profit margin %22.223.8 93.1%  
Effective tax rate %20.932.6 64.1%   
Net profit margin %14.919.2 77.5%  
BALANCE SHEET DATA
Current assets Rs m19,5776,984 280.3%   
Current liabilities Rs m14,8962,056 724.6%   
Net working cap to sales %11.972.6 16.4%  
Current ratio x1.33.4 38.7%  
Inventory Days Days9099 90.4%  
Debtors Days Days4524 189.4%  
Net fixed assets Rs m27,097244 11,091.6%   
Share capital Rs m377227 165.9%   
"Free" reserves Rs m26,8115,441 492.8%   
Net worth Rs m27,1885,668 479.7%   
Long term debt Rs m4,99325 19,972.0%   
Total assets Rs m47,7787,901 604.7%  
Interest coverage x41.7353.3 11.8%   
Debt to equity ratio x0.20 4,163.6%  
Sales to assets ratio x0.80.9 95.9%   
Return on assets %12.616.5 76.3%  
Return on equity %21.522.9 93.7%  
Return on capital %23.634.0 69.3%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m19,45315 127,978.3%   
Fx outflow Rs m6,0652,677 226.5%   
Net fx Rs m13,388-2,662 -502.9%   
CASH FLOW
From Operations Rs m8,120923 879.5%  
From Investments Rs m-7,556317 -2,384.3%  
From Financial Activity Rs m590-481 -122.7%  
Net Cashflow Rs m1,153759 151.9%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 2.9 11.3 25.7%  
FIIs % 9.1 7.2 126.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 30.4 45.7%  
Shareholders   49,328 21,978 224.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  ASTRAZENECA PHARMA  DIVIS LABORATORIES  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 25, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS